CAGR of pre-commercial biopharma pipeline by therapeutic worldwide 2010-2020

Published by
Matej Mikulic,
May 28, 2021
For the period 2010-2020, the compound annual growth rate of mRNA based therapeutics worldwide was 47 percent. This statistic illustrates the compound annual growth rate of the pre-commercial biopharma pipeline between 2010 and 2020, by type of therapeutic.

CAGR of pre-commercial biopharma pipeline worldwide for the period 2010-2020, by therapeutic

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

April 2021

Region

Worldwide

Survey time period

2010 to 2020

Citation formats
Statista Accounts: Access All Statistics. Starting from $588 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$69 USD $49 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you

Industry overview

5

Number of deals

7

Value of deals

5

Mega-merger: BMS/Celgene

5

2021 outlook

4

Further related statistics

12

Further Content: You might find this interesting as well

Statistics

Topics

Coronavirus (COVID-19) in JapanPharmaceutical industry in JapanTravel and tourism industry in JapanHealth care in JapanHospitals in Japan
Statista Accounts: Access All Statistics. Starting from $588 USD / Year
Learn more about how Statista can support your business.
Menu